Antibody response after second BNT162b2 dose in allogeneic HSCT recipients
- 13 July 2021
- journal article
- letter
- Published by Elsevier BV in The Lancet
- Vol. 398 (10297), 298-299
- https://doi.org/10.1016/s0140-6736(21)01594-4
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective surveyLeukemia, 2021
- Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant RecipientsJAMA, 2021
- Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2Nature Medicine, 2021
- Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort studyThe Lancet Haematology, 2021